Avalo Therapeutics (AVTX) Non-Current Debt (2014 - 2023)
Avalo Therapeutics (AVTX) reported Non-Current Debt of $10.47 million for Q1 2023, down 22.4% from the prior quarter.
Powered by 
Analysis
Avalo Therapeutics (AVTX) Non-Current Debt (2014 - 2023) Analysis & Trends
At the end of FY2022, Avalo Therapeutics posted Non-Current Debt of $13.49 million, down 58.9% from FY2021.
- Non-Current Debt has a four-year compound annual growth rate of -1.5% (FY2018 to FY2022).
- By year, Non-Current Debt came in at $32.83 million in FY2021 and $14.33 million in FY2018.
- The Q1 2023 figure ranks as the lowest quarterly Non-Current Debt since Q2 2016.
- Per Business Quant data, the three quarters before Q1 2023 came in at $13.49 million (Q4 2022), $16.5 million (Q3 2022) and $18.71 million (Q2 2022).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 47.86 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 37.34 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 62.48 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 51.08 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 1.96 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 23.68 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 51.86 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 23.83 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 60.50 Bn |
| 10 | Avalo Therapeutics | 533.82 Mn | -158.40 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2023 | 10.47 Mn |
| Dec 31, 2022 | 13.49 Mn |
| Sep 30, 2022 | 16.50 Mn |
| Jun 30, 2022 | 18.71 Mn |
| Mar 31, 2022 | 33.18 Mn |
| Dec 31, 2021 | 32.83 Mn |
| Sep 30, 2021 | 32.48 Mn |
| Jun 30, 2021 | 17.14 Mn |
| Sep 30, 2019 | 14.25 Mn |
| Jun 30, 2019 | 14.28 Mn |
| Mar 31, 2019 | 14.30 Mn |
| Dec 31, 2018 | 14.33 Mn |
| Sep 30, 2018 | 14.35 Mn |
| Jun 30, 2018 | 14.38 Mn |
| Mar 31, 2018 | 14.59 Mn |
| Jun 30, 2016 | 611,103.00 |
| Mar 31, 2016 | 1.49 Mn |
| Dec 31, 2015 | 2.35 Mn |
| Sep 30, 2015 | 3.20 Mn |
| Dec 31, 2014 | 5.31 Mn |
API Access
Avalo Therapeutics Non-Current Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-debt&ticker=AVTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-debt", "ticker": "AVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-debt&ticker=AVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();